Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiac magnetic resonance imaging

Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiac magnetic resonance imaging

Bibliographic Details
Main Authors:	Taylor Michael D, Cripe Linda S, Kinnett Kathi, Chung Eugene S, Al-Khalidi Hussein R, Mazur Wojciech, Hor Kan N, Williams Katelyn, Akula Nandakishore, Gottliebson William M, Benson D
Format:	Article
Language:	English
Published:	BMC 2011-02-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance
by: Kinnett Kathi J, et al.
Published: (2011-10-01)

Presence of mechanical dyssynchrony in duchenne muscular dystrophy
by: Akula Nandakishore, et al.
Published: (2011-02-01)

Serial assessment of myocardial T2 in Duchenne muscular dystrophy
by: Benson D, et al.
Published: (2011-02-01)

Left ventricular T2 distribution in Duchenne Muscular Dystrophy
by: Gottliebson William M, et al.
Published: (2009-01-01)

Left ventricular T2 distribution in Duchenne Muscular Dystrophy
by: Hagenbuch Sean, et al.
Published: (2010-03-01)

Presence of mechanical dyssynchrony in Duchenne Muscular dystrophy: a cardiac MRI study utilizing cross correlation delay
by: Chung Eugene S, et al.
Published: (2011-02-01)

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
by: Christopher F Spurney, et al.
Published: (2021-06-01)

Presence of late gadolinium enhancement in Duchenne muscular dystrophy patients is associated with age and global ventricular function
by: Hor Kan N, et al.
Published: (2012-02-01)

2080 Relationship of structural and functional cardiac abnormalities to respiratory status in Duchenne Muscular Dystrophy
by: Wansapura Janaka, et al.
Published: (2008-10-01)

Patient and caregiver perspectives on guideline adherence: the case of endocrine and bone health recommendations for Duchenne muscular dystrophy
by: Brian Denger, et al.
Published: (2019-08-01)

Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy
by: Machado Darlene L, et al.
Published: (2012-08-01)

Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989-05-01)

Increased susceptibility of the left lateral free wall to myocardial delayed enhancement in Duchenne Muscular Dystrophy: progressive systolic dysfunction demonstrable by CMR regional strain analysis
by: Benson D Woodrow, et al.
Published: (2009-01-01)

Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy
by: Elaine C. da Silva, et al.
Published: (2012-03-01)

P2RX7 purinoceptor as a therapeutic target in Duchenne muscular dystrophy
by: Al-khalidi, Rasha
Published: (2017)

Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013-07-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)

Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021-06-01)

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
by: Subha V. Raman, et al.
Published: (2017-02-01)

Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectives
by: Alexandra P. Q. C. Araujo, et al.

The ageing of the erythrocyte in relation to duchenne muscular dystrophy
by: Galbraith, D. A.
Published: (1979)

Regenerative biomarkers for Duchenne muscular dystrophy
by: Simon Guiraud, et al.
Published: (2019-01-01)

Delay in Diagnosis of Duchenne Muscular Dystrophy
by: Vamshi K Rao, et al.
Published: (2015-01-01)

Prednisone-Treated Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1991-06-01)

Language Delay in Duchenne’s Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)

Mortality cost of Duchenne muscular dystrophy
by: Erik Landfeldt, et al.
Published: (2017-04-01)

Epilepsy in Boys with Duchenne Muscular Dystrophy
by: M Etemadifar, et al.
Published: (2004-06-01)

Brain Function in Duchenne Muscular Dystrophy
by: J. Gordon Millichap
Published: (2002-02-01)

Nutritional Challenges in Duchenne Muscular Dystrophy
by: Simona Salera, et al.
Published: (2017-06-01)

Pain characterization in Duchenne muscular dystrophy
by: Talita Dias da Silva, et al.

Eteplirsen in the treatment of Duchenne muscular dystrophy
by: Lim KRQ, et al.
Published: (2017-02-01)

Early Development in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1990-07-01)

Molecular analysis of Duchenne muscular dystrophy
by: Smith, T. J.
Published: (1988)

Antisense therapies for Duchenne muscular dystrophy
by: Rabinowitz, Adam Howard
Published: (2007)

Genetic studies in Duchenne muscular dystrophy
by: Hodgson, Shirley V.
Published: (1987)

Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01)

Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01)

Duchenne Muscular Dystrophy—Insight and Treatment
by: Tay, Shaun Li Jian
Published: (2015)

Carrier detection in Duchenne muscular dystrophy
by: Freeman, Lesley Carolyn
Published: (1984)

Imaging biomarkers for Duchenne muscular dystrophy
by: Koppaka, Sisir
Published: (2017)